EuroIntervention PCRonline - Connecting with the community

Stephan Windecker

154 articles

Mid-term clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomized trials

EuroIntervention 2017; just accepted article published in July 2017

Neointima and neoatherosclerotic characteristics in bare metal and first and second generation drug eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study

EuroIntervention 2017; just accepted article published in June 2017

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial

EuroIntervention 2017;13:78-86 published online January 2017

Published in Volume 13 Number 1, May 2017

Current trends in structural heart interventions: an overview of the EAPCI registries

EuroIntervention 2017;13:Z11-Z13

Published in Volume 13 Supplement Z, May 2017

Current trends in coronary interventions: an overview from the EAPCI registries

EuroIntervention 2017;13:Z8-Z10

Published in Volume 13 Supplement Z, May 2017

EAPCI registries: a first step towards systematic monitoring of European interventional cardiology practice

EuroIntervention 2017;13:Z6-Z7

Published in Volume 13 Supplement Z, May 2017

Second Transcatheter Closure for Residual Shunt Following Percutaneous Closure of Patent Foramen Ovale

EuroIntervention 2017; just accepted article published in April 2017

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

EuroIntervention 2017;12:2018-2027 published online December 2016

Published in Volume 12 Number 17, April 2017

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

EuroIntervention 2017;12:e2186-e2193 published online January 2017 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis

EuroIntervention 2017;12:e2170-e2176 published online January 2017 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

A cardiac catheterisation laboratory core curriculum for the continuing professional development of nurses and allied health professions: developed by the Education working group of the Nurses and Allied Professions Committee for the European Association of Percutaneous Cardiovascular Interventions (EAPCI) 2016

EuroIntervention 2017;12:2028-2030 published online November 2016

Published in Volume 12 Number 16, March 2017

Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy

EuroIntervention 2017;12:1987-1994 published online November 2016

Published in Volume 12 Number 16, March 2017

Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)

EuroIntervention 2017;12:1934-1939

Published in Volume 12 Number 16, March 2017

The “hidden experiment”: percutaneous vs. surgical cut-down for transfemoral transcatheter aortic valve implantation

EuroIntervention 2017;12:1925-1926

Published in Volume 12 Number 16, March 2017

What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion?

EuroIntervention 2017;12:1684-1687

Published in Volume 12 Number 14, February 2017

Regulation of coronary stents – physicians as stakeholders

EuroIntervention 2017;12:1679-1680

Published in Volume 12 Number 14, February 2017

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

EuroIntervention 2017;12:1605-1613 published online October 2016

Published in Volume 12 Number 13, January 2017

Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION

EuroIntervention 2017;12:1577-1586 published online October 2016

Published in Volume 12 Number 13, January 2017

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

EuroIntervention 2016;12:e1343-e1354 published online ahead of print December 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

EuroIntervention 2016;12:e1336-e1342 published online ahead of print October 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015

Published in Volume 12 Number 10, November 2016

Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program

EuroIntervention 2016;12:1207-1214

Published in Volume 12 Number 10, November 2016

Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system

EuroIntervention 2016;12:1195

Published in Volume 12 Number 9, October 2016

Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

EuroIntervention 2016;12:1154-1163 published online ahead of print December 2015

Published in Volume 12 Number 9, October 2016

External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation

EuroIntervention 2016;12:1135-1143

Published in Volume 12 Number 9, October 2016

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability

EuroIntervention 2016;12:e1011-e1020 published online ahead of print November 2015 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment

EuroIntervention 2016;12:e987-e997 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Transcatheter mitral valve interventions: Eldorado or Waterloo for interventional cardiologists?

EuroIntervention 2016;12:Y56-Y57

Published in Volume 12 Supplement Y, September 2016

Welcome to PCR London Valves 2016: back to the UK

EuroIntervention 2016;12:Y5-Y6

Published in Volume 12 Supplement Y, September 2016

In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves

EuroIntervention 2016;12:909-917

Published in Volume 12 Number 7, September 2016

Current status of transcatheter valve therapy in Europe: results from an EAPCI survey

EuroIntervention 2016;12:890-895 published online ahead of print June 2016

Published in Volume 12 Number 7, September 2016

Durability of transcatheter heart valves – much ado about nothing

EuroIntervention 2016;12:819-820

Published in Volume 12 Number 7, September 2016

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

EuroIntervention 2016;12:e695-e604 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation

EuroIntervention 2016;12:490-498

Published in Volume 12 Number 4, July 2016

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

EuroIntervention 2016;12:482-489 published online ahead of print August 2015

Published in Volume 12 Number 4, July 2016

VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies

EuroIntervention 2016;12:375-380

Published in Volume 12 Number 3, June 2016

The plug for the appendage

EuroIntervention 2016;12:e290 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

Appraising the safety and efficacy profile of left atrial appendage closure in 2016 and the future clinical perspectives. Results of the EAPCI LAAC survey

EuroIntervention 2016;12:112-118

Published in Volume 12 Number 1, May 2016

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

EuroIntervention 2016;12:79-87

Published in Volume 12 Number 1, May 2016

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve

EuroIntervention 2016;12:71-77

Published in Volume 12 Number 1, May 2016

EAPCI Presidential “criss-cross”

EuroIntervention 2016;12:20-21

Published in Volume 12 Number 1, May 2016

Introducing a new EAPCI programme: the Valve for Life initiative

EuroIntervention 2016;11:977-979

Published in Volume 11 Number 9, January 2016

A vote taking place on 2 December 2015 (EUCOMED) that will definitely influence our profession and continuing medical education

EuroIntervention 2015;11:847-849

Published in Volume 11 Number 8, December 2015

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data

EuroIntervention 2015;11:746-756 published online ahead of print October 2014

Published in Volume 11 Number 7, November 2015

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions

EuroIntervention 2015;11:650-657 published online ahead of print July 2014

Published in Volume 11 Number 6, October 2015

Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries

EuroIntervention 2015;11:533-540 published online ahead of print June 2014

Published in Volume 11 Number 5, September 2015

Valvular heart disease: the unanswered questions

EuroIntervention 2015;11:W11-W13

Published in Volume 11 Supplement W, September 2015

Welcome to the special PCR London Valves 2015 supplement: a new team and venue, the same exceptional content

EuroIntervention 2015;11:W9

Published in Volume 11 Supplement W, September 2015

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

EuroIntervention 2015;11:391-398 published online ahead of print July 2014

Published in Volume 11 Number 4, August 2015

Notes from the EAPCI general assembly

EuroIntervention 2015;11:254-255

Published in Volume 11 Number 3, July 2015

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

EuroIntervention 2015;11:171-179

Published in Volume 11 Number 2, June 2015

Mapping interventional cardiology in Europe: proceedings of the 3rd Summit of the European Association of Percutaneous Cardiovascular Interventions

EuroIntervention 2015;11:27-28

Published in Volume 11 Number 1, May 2015

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

EuroIntervention 2015;11:68-74

Published in Volume 11 Number 1, May 2015

European expert consensus on rotational atherectomy

EuroIntervention 2015;11:30-36

Published in Volume 11 Number 1, May 2015

EuroIntervention at ten years

EuroIntervention 2015;11:25-26

Published in Volume 11 Number 1, May 2015

Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials

EuroIntervention 2015;10:1425-1431 published online ahead of print February 2014

Published in Volume 10 Number 12, April 2015

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

EuroIntervention 2015;10:1299-1306 published online ahead of print April 2014

Published in Volume 10 Number 11, March 2015

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

EuroIntervention 2015;10:1284-1287 published online ahead of print January 2015

Published in Volume 10 Number 11, March 2015

The EAPCI and continuing education for Fellows

EuroIntervention 2015;10:1258-1259

Published in Volume 10 Number 11, March 2015

Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation

EuroIntervention 2015;10:e1-e8 published online e-article February 2015

Published in Volume 10 Number 10, February 2015

2014 ESC/EACTS Guidelines on myocardial revascularization

EuroIntervention 2015;10:1024-1094  published online ahead of print September 2014

Published in Volume 10 Number 9, January 2015

Standards of care: The EAPCI, guidelines and consensus documents

EuroIntervention 2015;10:1022-1023

Published in Volume 10 Number 9, January 2015

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

EuroIntervention 2015;10:1015-1021

Published in Volume 10 Number 9, January 2015

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

EuroIntervention 2014;10:982-989 published online ahead of print April 2014

Published in Volume 10 Number 8, December 2014

PCR London Valves: a very special year

EuroIntervention 2014;10:781-783

Published in Volume 10 Number 7, November 2014

Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement

EuroIntervention 2014;10:732-738

Published in Volume 10 Number 6, October 2014

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

EuroIntervention 2014;10:U120-U128

Published in Volume 10 Supplement U, September 2014

Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat

EuroIntervention 2014;10:U69-U75

Published in Volume 10 Supplement U, September 2014

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

EuroIntervention 2014;10:U61-U68

Published in Volume 10 Supplement U, September 2014

Welcome to PCR London Valves 2014

EuroIntervention 2014;10:U7-U9

Published in Volume 10 Supplement U, September 2014

The role of the EAPCI in producing scientific documents and articles

EuroIntervention 2014;10:542-544

Published in Volume 10 Number 5, September 2014

Management of ST-elevation myocardial infarction according to European and American guidelines

EuroIntervention 2014;10-T23-T31

Published in Volume 10 Supplement T, August 2014

STEMI: the EAPCI and Stent for Life Initiative

EuroIntervention 2014;10-T9

Published in Volume 10 Supplement T, August 2014

Focus on EAPCI committees

EuroIntervention 2014;10:428-430

Published in Volume 10 Number 4, August 2014

Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement

EuroIntervention 2014;10:339-346 published online ahead of print November 2013

Published in Volume 10 Number 3, July 2014

Sustained progress through continuity: a new presidential criss-cross

EuroIntervention 2014;10:299-301

Published in Volume 10 Number 3, July 2014

Flow disturbances in stent-related coronary evaginations: a computational fluid-dynamic simulation study

EuroIntervention 2014;10:113-123 published online ahead of print November 2013

Published in Volume 10 Number 1, May 2014

Unmet needs of young interventional cardiologists: proceedings from the 2nd Summit of the European Association of Percutaneous Cardiovascular Interventions

EuroIntervention 2014;10:47-49

Published in Volume 10 Number 1, May 2014

Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups

EuroIntervention 2014;10:31-37

Published in Volume 10 Number 1, May 2014

Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts

EuroIntervention 2014;9:1432-1440 published online ahead of print August 2013

Published in Volume 9 Number 12, April 2014

Intricacies in the analysis and interpretation of optical coherence tomography findings

EuroIntervention 2014;9:1374-1377

Published in Volume 9 Number 12, April 2014

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013

Published in Volume 9 Number 11, March 2014

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

EuroIntervention 2014;9:1085-1094 published online ahead of print August 2013

Published in Volume 9 Number 9, January 2014

Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents

EuroIntervention 2014;9:1076-1084 published online ahead of print August 2013

Published in Volume 9 Number 9, January 2014

Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?

EuroIntervention 2013;9:909-915

Published in Volume 9 Number 8, December 2013

Unmet needs of young interventional cardiologists: the EAPCI Young survey

EuroIntervention 2013;9:903-908

Published in Volume 9 Number 8, December 2013

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

EuroIntervention 2013;9:709-720 published online ahead of print April 2013

Published in Volume 9 Number 6, October 2013

Severe aortic stenosis and coronary artery disease

EuroIntervention 2013;9:S63-S68

Published in Volume 9 Supplement S, September 2013

Transcatheter aortic valve implantation: the transfemoral access route is the default access

EuroIntervention 2013;9:S14-S18

Published in Volume 9 Supplement S, September 2013

Welcome to PCR London Valves 2013

EuroIntervention 2013;9:S7

Published in Volume 9 Supplement S, September 2013

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

EuroIntervention 2013;8:1362-1371

Published in Volume 8 Number 12, April 2013

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

EuroIntervention 2013;8:1061-1071

Published in Volume 8 Number 9, January 2013

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

EuroIntervention 2012;8:782-795

Published in Volume 8 Number 7, November 2012

Transcatheter aortic valve implantation and cerebrovascular accidents

EuroIntervention 2012;8:Q60-Q69

Published in Volume 8 Supplement Q, September 2012

Welcome to PCR London Valves 2012

EuroIntervention 2012;8:Q7

Published in Volume 8 Supplement Q, September 2012

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

EuroIntervention 2012;8:437-443

Published in Volume 8 Number 4, August 2012

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial

EuroIntervention 2012;8:352-358 published online ahead of print November 2011

Published in Volume 8 Number 3, July 2012

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes

EuroIntervention 2012;8:325-335

Published in Volume 8 Number 3, July 2012

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

EuroIntervention 2012;8:258-266 publish online ahead of print March 2012

Published in Volume 8 Number 2, June 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques

EuroIntervention 2012;8:98-108

Published in Volume 8 Number 1, May 2012

Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes

EuroIntervention 2012;8:62-70

Published in Volume 8 Number 1, May 2012

Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design

EuroIntervention 2012;7:1435-1443 publish online ahead of print February 2012

Published in Volume 7 Number 12, April 2012

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

EuroIntervention 2011;7:789-795 publish online ahead of print October 2011

Published in Volume 7 Number 7, November 2011

Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study

EuroIntervention 2011;7:697-704

Published in Volume 7 Number 6, October 2011

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

EuroIntervention 2011;7:605-613 publish online ahead of print June 2011

Published in Volume 7 Number 5, September 2011

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

EuroIntervention 2011;7:541-548

Published in Volume 7 Number 5, September 2011

Continuity and innovation: the yin and yang of interventional cardiology

EuroIntervention 2011;7:1-427

Published in Volume 7 Number 4, August 2011

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application

EuroIntervention 2011;7:386-399 published online ahead of print January 2011

Published in Volume 7 Number 3, July 2011

Feasibility and safety of percutaneous management of vascular access site complications - implications for transfemoral aortic valve implantation

Published in Volume 7 Supplement M, May 2011

Transcatheter left atrial appendage occlusion in atrial fibrillation: comparison of non-dedicated vs. dedicated Amplatzer devices

Published in Volume 7 Supplement M, May 2011

Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing conservative treatment or TAVI

Published in Volume 7 Supplement M, May 2011

The impact of coronary artery disease on clinical outcomes in patients undergoing TAVI

Published in Volume 7 Supplement M, May 2011

Quality of life in patients undergoing percutaneous aortic valve implantation

Published in Volume 7 Supplement M, May 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

Published in Volume 7 Supplement M, May 2011

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography

Published in Volume 7 Supplement M, May 2011

Long-term tissue coverage of a bioresorbable polylactide polymer-coated Biolimus-eluting stent: comparative sequential assessment with optical coherence tomography till complete resorption of the polymer

Published in Volume 7 Supplement M, May 2011

Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE all-comers trial

Published in Volume 7 Supplement M, May 2011

Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence study

Published in Volume 7 Supplement M, May 2011

Conformability of the Nevo; Sirolimus-eluting coronary stent system in comparison with the Xience; Everolimus-eluting coronary stent system: results from a bench top study and an angiographic assessment from the Nevo II clinical trial

Published in Volume 7 Supplement M, May 2011

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

Published in Volume 7 Supplement M, May 2011

Pooled analysis of the Resolute programme clinical safety results

Published in Volume 7 Supplement M, May 2011

Treatment with the Resolute Zotarolimus-eluting stent in subjects with diabetes mellitus: pooled analysis from the Resolute clinical programme

Published in Volume 7 Supplement M, May 2011

Incidence of stent thrombosis in two large registries in Europe and Japan: a patient level data analysis from the Bern-Rotterdam and J-CYPHER registries

Published in Volume 7 Supplement M, May 2011

Impact of stent thrombosis on clinical outcomes among patients undergoing PCI with newer generation DES

Published in Volume 7 Supplement M, May 2011

The impact of anemia on long-term clinical outcome in patients undergoing PCI

Published in Volume 7 Supplement M, May 2011

e-BioMatrix PMS Registry - A post market surveillance registry for the BioMatrix™ drug-eluting stent

Published in Volume 7 Supplement M, May 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

EuroIntervention 2011;6:928-935

Published in Volume 6 Number 8, March 2011

Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study

EuroIntervention 2010;6:467-474 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

EuroIntervention 2010;6:233-239

Published in Volume 6 Number 2, June 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205

Published in Volume 6 Number 2, June 2010

Scientific societies and clinical trials

EuroIntervention 2010;6:185-188

Published in Volume 6 Number 2, June 2010

Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial

EuroIntervention 2010;6:63-68

Published in Volume 6 Number 1, May 2010

Long-term survival of elderly patients with severe aortic stenosis as function of treatment selection

Published in Volume 6 Supplement H, May 2010

Figulla patent foramen ovale occluder vs. Amplatzer patent foramen ovale occluder: a single-centre experience comparing both devices for percutaneous closure of patent foramen ovale

Published in Volume 6 Supplement H, May 2010

Anatomic characteristics of the aortic root in elderly patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation

Published in Volume 6 Supplement H, May 2010

Five-year outcome after implantation of sirolimus-eluting (SES) and paclitaxel-eluting (SES) stents in diabetic patients

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

Published in Volume 6 Supplement H, May 2010

Malapposed struts in drug-eluting stents entail higher risk of incomplete tissue coverage at 9- to 13-month follow-up compared to well-apposed struts: in vivo demonstration with optical coherence tomography

Published in Volume 6 Supplement H, May 2010

Implications of floating struts at side branches in the tissue coverage of drug-eluting stents at 9- to 13-months follow-up: in vivo assessment with optical coherence tomography

Published in Volume 6 Supplement H, May 2010

Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study

Published in Volume 6 Supplement H, May 2010

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

EuroIntervention 2010;5:871-874

Published in Volume 5 Number 7, February 2010

Vascular restoration therapy: what should the clinical and angiographic measures for success be?

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F49-F53

Published in Volume 5 Supplement F, December 2009

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study

EuroIntervention 2009;5:580-588

Published in Volume 5 Number 5, November 2009

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy

EuroIntervention 2009;5:310-317 - DOI10.4244/EIJV5I3A49

Published in Volume 5 Number 3, August 2009

The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer

Published in Volume 5 Supplement E, May 2009

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of severe aortic stenosis: a two-center propensity score analysis study

Published in Volume 5 Supplement E, May 2009

Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

EuroInterv.2009;4:427-436

Published in Volume 4 Number 4, January 2009

An introduction to "A critical appraisal of the safety concerns tempering the success of drug-eluting stents"

EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C5-C6

Published in Volume 4 Supplement C, August 2008

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

EuroIntervention 2008;4:242-249 - DOI10.4244/EIJV4I2A43

Published in Volume 4 Number 2, August 2008

Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations

EuroInterv.2008;4:181-192

Published in Volume 4 Number 2, August 2008

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

EuroInterv.2008;4:77-83

Published in Volume 4 Number 1, May 2008

Stent coating with titanium-nitride-oxide for prevention of restenosis

EuroInterv.2006;2:146-148

Published in Volume 2 Number 2, August 2006